bromperidol has been researched along with beta-(4-fluorobenzoyl)propionic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Digenis, GA; Kook, CS; Reiman, RE; Russ, GA; Tilbury, RS; Vincent, SH | 1 |
| Kobayashi, S; Kumai, T; Tanaka, M; Tateishi, T; Watanabe, M | 1 |
| Kobayashi, S; Kumai, T; Moriya, H; Satoh, T; Tanaka, M; Tateishi, T; Watanabe, M; Yamaguchi, S | 1 |
3 other study(ies) available for bromperidol and beta-(4-fluorobenzoyl)propionic acid
| Article | Year |
|---|---|
Tissue distribution studies of [18F]haloperidol, [18F]-beta-(4-fluorobenzoyl)propionic acid, and [82Br]bromperidol by external scintigraphy.
Topics: Animals; Bromine Radioisotopes; Fluorine Radioisotopes; Haloperidol; Macaca mulatta; Male; Propionates; Rats; Rats, Sprague-Dawley; Tissue Distribution | 1981 |
Role of CYP3A in bromperidol metabolism in rat in vitro and in vivo.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Enzyme Inhibitors; Erythromycin; Half-Life; Haloperidol; Immune Sera; Male; Microsomes, Liver; Oxidoreductases, N-Demethylating; Propionates; Quinine; Rats; Rats, Sprague-Dawley; Steroid Hydroxylases; Theophylline; Troleandomycin | 1999 |
CYP3A is responsible for N-dealkylation of haloperidol and bromperidol and oxidation of their reduced forms by human liver microsomes.
Topics: Aryl Hydrocarbon Hydroxylases; Biotransformation; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Haloperidol; Humans; In Vitro Techniques; Microsomes, Liver; Mixed Function Oxygenases; Oxidation-Reduction; Oxidoreductases, N-Demethylating; Propionates; Troleandomycin | 2000 |